Anaptysbio (ANAB) Cash & Current Investments (2016 - 2026)
Anaptysbio (ANAB) reported Cash & Current Investments of $286.46 million for Q1 2026, down 15.7% from $339.94 million a year earlier and down 8.1% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Cash & Current Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, Anaptysbio posted Cash & Current Investments of $311.64 million, down 19.1% from FY2024.
- Cash & Current Investments has declined for four consecutive years, with a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $385.37 million in FY2024 (-1.4%), $390.9 million in FY2023 (-11.4%), $441.24 million in FY2022 (-19.5%) and $548.1 million in FY2021 (+39.2%).
- Five-year quarterly Cash & Current Investments spans a low of $248.96 million in Q3 2025 and a high of $548.1 million in Q4 2021.
- Year over year, Cash & Current Investments has now declined in each of the last six quarters, with an average decline of 15.1% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was Q4 2021 (growth of 39.2%); the low point was Q3 2025 (a decline of 42.1%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $311.64 million (Q4 2025), $248.96 million (Q3 2025) and $265.71 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Anaptysbio | 1.41 Bn | 296.12 Mn | - | 286.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 286.46 Mn |
| Dec 31, 2025 | 311.64 Mn |
| Sep 30, 2025 | 248.96 Mn |
| Jun 30, 2025 | 265.71 Mn |
| Mar 31, 2025 | 339.94 Mn |
| Dec 31, 2024 | 385.37 Mn |
| Sep 30, 2024 | 430.12 Mn |
| Jun 30, 2024 | 350.80 Mn |
| Mar 31, 2024 | 354.67 Mn |
| Dec 31, 2023 | 390.90 Mn |
| Sep 30, 2023 | 413.05 Mn |
| Jun 30, 2023 | 429.49 Mn |
| Mar 31, 2023 | 431.15 Mn |
| Dec 31, 2022 | 441.24 Mn |
| Sep 30, 2022 | 442.97 Mn |
| Jun 30, 2022 | 442.15 Mn |
| Mar 31, 2022 | 505.62 Mn |
| Dec 31, 2021 | 548.10 Mn |
| Sep 30, 2021 | 374.06 Mn |
| Jun 30, 2021 | 390.85 Mn |
API Access
Anaptysbio Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();